TrialBone marrow transplantation2003

Methotrexate vs Cyclosporin A as a single agent for graft-versus-host disease prophylaxis in pediatric patients with hematological malignancies undergoing allogeneic bone marrow transplantation from HLA-identical siblings: a single-center analysis in Japan.

Y Koga et al.PubMed ↗Publisher ↗

No numbers read from the abstract.